|
Market Closed -
Swiss Exchange
16:31:43 15/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 14.58 CHF | +3.55% |
|
+9.13% | +145.04% |
| 10-15 | Swiss Market Index Holds Gains; Richemont Reportedly in Talks to Join Consortium Bidding for De Beers | MT |
| 10-15 | DocMorris AG : Jefferies reiterates its Neutral rating | ZD |
Company Valuation: DocMorris AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,412 | 320.6 | 860.2 | 257.7 | 289.2 | 736.1 | - | - |
| Change | - | -86.71% | 168.32% | -70.05% | 12.22% | 154.57% | - | - |
| Enterprise Value (EV) 1 | 2,714 | 723.2 | 1,137 | 486.1 | 426.8 | 938 | 973 | 968.8 |
| Change | - | -73.36% | 57.22% | -57.25% | -12.21% | 119.79% | 3.74% | -0.43% |
| P/E | -10.1x | -1.61x | 10.5x | -2.42x | -1.71x | -9.11x | -20.7x | -305x |
| PBR | 5.44x | 0.84x | 2.01x | 0.69x | 0.7x | 2.27x | 2.44x | 2.42x |
| PEG | - | 0.1x | -0x | 0x | 0x | 0.2x | 0.4x | 3.3x |
| Capitalization / Revenue | 1.4x | 0.2x | 0.89x | 0.25x | 0.26x | 0.58x | 0.52x | 0.48x |
| EV / Revenue | 1.57x | 0.45x | 1.18x | 0.48x | 0.38x | 0.74x | 0.69x | 0.63x |
| EV / EBITDA | -19x | -9.31x | -29.6x | -10x | -8.85x | -117x | 43.7x | 18.5x |
| EV / EBIT | -14x | -5.15x | -13.7x | -5.41x | -4.41x | -14.9x | -41.3x | 213x |
| EV / FCF | -14x | -3.87x | -9.88x | -8.81x | -3.68x | -11.8x | -27.6x | -67.3x |
| FCF Yield | -7.15% | -25.9% | -10.1% | -11.4% | -27.2% | -8.48% | -3.63% | -1.49% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.4 | -15.88 | 7.05 | -8.25 | -3.47 | -1.6 | -0.7044 | -0.0478 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,726 | 1,608 | 966.9 | 1,017 | 1,124 | 1,262 | 1,408 | 1,541 |
| EBITDA 1 | -142.6 | -77.7 | -38.4 | -48.6 | -48.24 | -8 | 22.26 | 52.35 |
| EBIT 1 | -193.8 | -140.3 | -83.2 | -89.8 | -96.86 | -62.84 | -23.58 | 4.555 |
| Net income 1 | -225.7 | -171.1 | 82.2 | -97.3 | -134.4 | -85.94 | -41.26 | -13.31 |
| Net Debt 1 | 302.8 | 402.6 | 276.8 | 228.4 | 137.6 | 201.8 | 236.9 | 232.7 |
| Reference price 2 | 235.50 | 25.56 | 73.75 | 19.98 | 5.95 | 14.58 | 14.58 | 14.58 |
| Nbr of stocks (in thousands) | 10,240 | 12,543 | 11,664 | 12,897 | 48,599 | 50,489 | - | - |
| Announcement Date | 24/03/22 | 24/03/23 | 20/03/24 | 12/03/25 | 18/03/26 | - | - | - |
1CHF in Million2CHF
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.8x | 0.72x | -53.66x | -.--% | 847M | |
| 16.89x | 0.69x | 10.22x | -.--% | 15.09B | |
| 24.34x | 0.98x | 10.61x | 1.83% | 7.24B | |
| 16.1x | 0.71x | 7.4x | 2.33% | 6.12B | |
| 19.9x | 0.34x | 5.3x | 2.29% | 6.01B | |
| 19.89x | 0.73x | 12.57x | 1.1% | 5.92B | |
| 16.35x | 1.02x | 7.15x | 2.58% | 4.6B | |
| 16.36x | 0.99x | 7.43x | 3.96% | 3.33B | |
| 14.57x | 0.62x | 4.78x | 4.96% | 3.23B | |
| 15.37x | 0.45x | 7.46x | 1.37% | 3.11B | |
| Average | 15.10x | 0.72x | 1.93x | 2.04% | 5.55B | |
| Weighted average by Cap. | 17.73x | 0.72x | 7.81x | 1.68% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ROSE Stock
- Valuation DocMorris AG
Select your edition
All financial news and data tailored to specific country editions
